Lecture 30: Alzheimer's Disease (Amyloid Beta and Synaptic Plasticity)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/41

encourage image

There's no tags or description

Looks like no tags are added yet.

42 Terms

1
New cards

What are some statistics for Alzheimer’s Disease?

  • the 6th leading cause of death in the US

  • 5.3 million Americans currently have AD

  • 50% of people age 85 and older have AD

  • AD is not a normal part of aging


2
New cards

What is the histopathology of AD?

  • amyloid plaques

  • neurofibrillary tangles


3
New cards

What are the characteristics of amyloid plaques?

  • accumulate between neurons

  • insoluble B-amyloid


4
New cards

What are the characteristics neurofibrillary tangles?

  • accumulate in neurons

  • abnormal Tau


5
New cards

How does β-amyloid immunostaining detect plaques?

An anti-Aβ antibody binds Aβ, and a reaction makes a brown color there

6
New cards

How does silver impregnation differ from Aβ immunostaining?

It is less specific: it stains plaques plus neurites and tangles

7
New cards

In silver-stained neuritic plaques, what surrounds the dense amyloid core?

A halo of swollen, dystrophic neurites

8
New cards

Where are amyloid plaques located relative to neurons?

Extracellular, between neurons

9
New cards

What are the characteristics of amyloid beta?

  • a peptide of 39-43 amino acids

  • the main constituent of amyloid plaques, plaques in Lewy body dementia, and cerebral amyloid angiopathy


10
New cards

What are the most common isoforms of amyloid beta?

  • AB40 (more common) - produced in the ER

  • AB42 (more fibrillogenic) - produced in the TGN


11
New cards

How is amyloid beta formed?

formed after sequential cleavage of the amyloid precursor protein (APP) by B-secretase and y-secretase

12
New cards

What does AD dementia correlate strongly with?

  • soluble AB abundance

  • decreased spine density


13
New cards

What does AD dementia correlate poorly with?

amyloid plaques

14
New cards

What happens in a high level of AB (1-42)?

does not induce plaques in vivo

15
New cards

What does soluble AB do?

impairs synapse physiology in the absence of amyloid plaques

16
New cards

What is true of amyloid plaques in synapse physiology and neurotoxicity?

  • synapse loss around the amyloid plaque cores in AD mice

  • fibrillary amyloid aggregates cause neurotoxicity


17
New cards

What is true of AB in synapse physiology and neurotoxicity?

  • AB forms multiple oligomers

  • soluble AB oligomers kill neurons at nM concentration

  • synthetic or cell-derived soluble AB oligomers potently inhibit hippocampal LTP, but induces LTD before toxicity

  • AB causes synapses and spine loss even without plaques

  • AB toxicity via modulation of NMDAR, mGluR, and nAChR


18
New cards

What was the main gap in the field that Shankar et al. 2008 addressed?

The pathogenic Aβ species in the human brain had not been identified, and Aβ from human AD brain had not been shown to directly cause AD's neurobiological deficits

19
New cards

State the central hypothesis of Shankar et al. 2008.

Soluble Aβ oligomers extracted directly from human AD cortex impair synaptic plasticity and memory, with dimers as the smallest synaptotoxic species.

20
New cards

What three fractions were brain homogenates separated into, and with what?

Soluble (TBS), membrane-associated (TBS + 1% Triton X-100), insoluble (5 M guanidine HCl)

21
New cards

Why fractionate at all, rather than just blot whole homogenate?

Different pools may differ in disease relevance; dementia correlates with soluble Aβ, so they needed to know which pool held what

22
New cards

What made the P-AD (pathological AD, no dementia) case so informative in Figure 1?

Aβ appeared in its insoluble but not its soluble fraction — plaques without dementia, and without soluble Aβ

23
New cards

What happened to LTP with AD TBS versus control TBS (Fig. 2b)?

AD TBS reduced LTP to ~111% of baseline; Veh and Con TBS gave ~153% and ~144%

24
New cards

What two controls showed the LTP inhibition was specifically due to Aβ from AD brain?

Immunodepletion with R1282 prevented it, and DLB/FTD extracts did not inhibit LTP

25
New cards

Why was a subthreshold LFS protocol (300 pulses at 1 Hz) used for the LTD experiment?

It is too weak to induce LTD alone, so any LTD reveals facilitation by AD TBS

26
New cards

Which receptor is required for AD TBS–facilitated LTD, and what is the evidence?

mGluR: MCPG and SIB1757 blocked it, but the NMDAR antagonist AP-V did not

27
New cards

How does the passive avoidance test measure memory?

Rodents prefer dark; a foot shock there means a long latency to re-enter indicates intact memory

28
New cards

At which post-training injection time did AD TBS impair recall, and what does that timing imply?

3 h only — matching the transcriptional regulation of synapse remodeling, so it disrupts consolidation

29
New cards

Why is dendritic spine density the right readout for structural damage in AD?

Decreased spine density is the strongest neuropathological correlate of dementia severity in AD

30
New cards

What was the spine density result, and which antagonist blocked it?

AD TBS-SEC caused a 47% decrease; CPP (NMDAR) blocked it, MCPG (mGluR) did not

31
New cards

What is the double dissociation between the LTD and spine density experiments?

mGluRs are required for LTD facilitation; NMDARs are required for spine loss

32
New cards

In nondenaturing SEC of AD TBS, which fraction inhibited LTP?

Fraction 8 (dimers, ~8–16 kDa); fractions 4 (void) and 10 (monomers) were inactive

33
New cards

Fraction 4 had the highest Aβ concentration but no activity. Why?

Its high-MW complexes are held together noncovalently and only dissociate into monomers and dimers when denatured in LDS-PAGE

34
New cards

What is the Aβ40-S26C experiment, and what does it prove?

A synthetic peptide engineered to dimerize on oxidation; oxidized dimer inhibited LTP ~20× more potently than WT, proving Aβ dimers alone are sufficient

35
New cards

Did insoluble amyloid cores alter LTP (Fig. 4)?

Intact cores in ACSF did not; formic acid extracts of those same cores did

36
New cards

How does Figure 4 resolve the poor correlation between plaque burden and dementia?

Plaques are relatively inert reservoirs of bioactive oligomers — they contain synaptotoxic dimers but don't readily release them

37
New cards

What is the single most important result of Shankar et al. 2008?

Soluble Aβ isolated directly from human AD brain is sufficient to produce AD-like synaptic and memory deficits in normal rodents

38
New cards

What is the second key result, about which Aβ species is responsible?

Dimers are the smallest synaptotoxic species; monomers and intact plaque cores are inactive

39
New cards

Why do the authors hedge on the receptor double dissociation as a "key result"?

They state these receptors are unlikely to be the sole effector targets of soluble Aβ oligomers

40
New cards

Does this paper fill the stated gap in the field?

Substantially yes — it identifies the pathogenic species and shows human-brain Aβ causes the deficits — but acute rodent assays don't fully model a decades-long disease

41
New cards

What is the overall significance of Shankar et al. 2008?

It identified soluble Aβ dimers from human AD brain as a synaptotoxic species sufficient to cause AD-like deficits, shifting the therapeutic target from plaques to soluble oligomers

42
New cards

Which future directions did the authors themselves raise?

Identify effector targets beyond mGluR/NMDAR; resolve why Aβ*56 wasn't detected in human extracts; determine the role of CSF dimers